Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes
on page 1 showing 20 out of 483 results from 1 sources
http://web.expasy.org/cellosaurus/CVCL_1733

Cite this ATCC Cat# HTB-118, RRID:CVCL_1733
Organism: Homo sapiens
Disease: Vulvar carcinoma
Category: Cancer cell line
Comment: From: Scott and White Clinic; Temple; Texas; USA. Microsatellite instability: Stable (MSS) (Sanger). Omics: Deep exome analysis. Omics: DNA methylation analysis.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0023

Cite this DSMZ Cat# ACC-107, RRID:CVCL_0023
Organism: Homo sapiens
Disease: Lung adenocarcinoma
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 2. Part of: JFCR39 cancer cell line panel. Part of: KuDOS 95 cell line panel. Part of: MD Anderson Cell Lines Project. Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982). Part of: NCI60 cancer cell line panel. Doubling time: 18 hours (in RPMI 1640+10% FBS), 37 hours (in ACL-3), 36 hours (in ACL-3+BSA) (PubMed=3940644); 22 hours (PubMed=25984343); 27 hours (from cell counting), 27 hours (from absorbance) (DOI=10.5897/IJBMBR2013.0154); 22.9 hours (NCI-DTP); ~40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger). Sequence variation: Homozygous for KRAS p.Gly12Ser (PubMed=17088437). Sequence variation: Homozygous for STK11 p.Gln37Ter (PubMed=17088437). Omics: Acetylation analysis by proteomics. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep phosphoproteome analysis. Omics: Deep membrane proteome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: H3K9ac ChIP-seq epigenome analysis. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: Proteome analysis by 2D-DE/MS. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Omics: Virome analysis using proteomics. Misspelling: 'A594' in PubMed=18227028. Misspelling: 'A59' in PubMed=16354588. Discontinued: ATCC; CRL-7909.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0023

Cite this ATCC Cat# CRL-7909, RRID:CVCL_0023
Organism: Homo sapiens
Disease: Lung adenocarcinoma
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 2. Part of: JFCR39 cancer cell line panel. Part of: KuDOS 95 cell line panel. Part of: MD Anderson Cell Lines Project. Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982). Part of: NCI60 cancer cell line panel. Doubling time: 18 hours (in RPMI 1640+10% FBS), 37 hours (in ACL-3), 36 hours (in ACL-3+BSA) (PubMed=3940644); 22 hours (PubMed=25984343); 27 hours (from cell counting), 27 hours (from absorbance) (DOI=10.5897/IJBMBR2013.0154); 22.9 hours (NCI-DTP); ~40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger). Sequence variation: Homozygous for KRAS p.Gly12Ser (PubMed=17088437). Sequence variation: Homozygous for STK11 p.Gln37Ter (PubMed=17088437). Omics: Acetylation analysis by proteomics. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep phosphoproteome analysis. Omics: Deep membrane proteome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: H3K9ac ChIP-seq epigenome analysis. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: Proteome analysis by 2D-DE/MS. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Omics: Virome analysis using proteomics. Misspelling: 'A594' in PubMed=18227028. Misspelling: 'A59' in PubMed=16354588. Discontinued: ATCC; CRL-7909.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0022

Cite this KCLB Cat# 30014, RRID:CVCL_0022
Organism: Homo sapiens
Disease: Glioblastoma
Category: Cancer cell line
Comment: Problematic cell line: Contaminated/misidentified. This cell line is not the original glioblastoma cell line established in 1968 at the University of Uppsala. As described in PubMed=27582061 it is most probably also a glioblastoma cell line but whose origin is unknow. See U-87MG Uppsala (CVCL_GP63) for the original U-87MG cell line. Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 3. Doubling time: 72 hours (PubMed=25984343). Microsatellite instability: Stable (MSS) (Sanger). Sequence variation: Has no IDH1 mutation (PubMed=19435942). Omics: Cell surface proteome. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Genome sequenced. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Discontinued: RCB; RCB0419.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0022

Cite this NCBI_Iran Cat# C531, RRID:CVCL_0022
Organism: Homo sapiens
Disease: Glioblastoma
Category: Cancer cell line
Comment: Problematic cell line: Contaminated/misidentified. This cell line is not the original glioblastoma cell line established in 1968 at the University of Uppsala. As described in PubMed=27582061 it is most probably also a glioblastoma cell line but whose origin is unknow. See U-87MG Uppsala (CVCL_GP63) for the original U-87MG cell line. Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 3. Doubling time: 72 hours (PubMed=25984343). Microsatellite instability: Stable (MSS) (Sanger). Sequence variation: Has no IDH1 mutation (PubMed=19435942). Omics: Cell surface proteome. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Genome sequenced. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Discontinued: RCB; RCB0419.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0022

Cite this NIH-ARP Cat# 2188-324, RRID:CVCL_0022
Organism: Homo sapiens
Disease: Glioblastoma
Category: Cancer cell line
Comment: Problematic cell line: Contaminated/misidentified. This cell line is not the original glioblastoma cell line established in 1968 at the University of Uppsala. As described in PubMed=27582061 it is most probably also a glioblastoma cell line but whose origin is unknow. See U-87MG Uppsala (CVCL_GP63) for the original U-87MG cell line. Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 3. Doubling time: 72 hours (PubMed=25984343). Microsatellite instability: Stable (MSS) (Sanger). Sequence variation: Has no IDH1 mutation (PubMed=19435942). Omics: Cell surface proteome. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Genome sequenced. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Discontinued: RCB; RCB0419.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0022

Cite this BCRC Cat# 60360, RRID:CVCL_0022
Organism: Homo sapiens
Disease: Glioblastoma
Category: Cancer cell line
Comment: Problematic cell line: Contaminated/misidentified. This cell line is not the original glioblastoma cell line established in 1968 at the University of Uppsala. As described in PubMed=27582061 it is most probably also a glioblastoma cell line but whose origin is unknow. See U-87MG Uppsala (CVCL_GP63) for the original U-87MG cell line. Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 3. Doubling time: 72 hours (PubMed=25984343). Microsatellite instability: Stable (MSS) (Sanger). Sequence variation: Has no IDH1 mutation (PubMed=19435942). Omics: Cell surface proteome. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Genome sequenced. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Discontinued: RCB; RCB0419.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0022

Cite this ATCC Cat# HTB-14, RRID:CVCL_0022
Organism: Homo sapiens
Disease: Glioblastoma
Category: Cancer cell line
Comment: Problematic cell line: Contaminated/misidentified. This cell line is not the original glioblastoma cell line established in 1968 at the University of Uppsala. As described in PubMed=27582061 it is most probably also a glioblastoma cell line but whose origin is unknow. See U-87MG Uppsala (CVCL_GP63) for the original U-87MG cell line. Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 3. Doubling time: 72 hours (PubMed=25984343). Microsatellite instability: Stable (MSS) (Sanger). Sequence variation: Has no IDH1 mutation (PubMed=19435942). Omics: Cell surface proteome. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Genome sequenced. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Discontinued: RCB; RCB0419.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0022

Cite this KCB Cat# KCB 2011101YJ, RRID:CVCL_0022
Organism: Homo sapiens
Disease: Glioblastoma
Category: Cancer cell line
Comment: Problematic cell line: Contaminated/misidentified. This cell line is not the original glioblastoma cell line established in 1968 at the University of Uppsala. As described in PubMed=27582061 it is most probably also a glioblastoma cell line but whose origin is unknow. See U-87MG Uppsala (CVCL_GP63) for the original U-87MG cell line. Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 3. Doubling time: 72 hours (PubMed=25984343). Microsatellite instability: Stable (MSS) (Sanger). Sequence variation: Has no IDH1 mutation (PubMed=19435942). Omics: Cell surface proteome. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Genome sequenced. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Discontinued: RCB; RCB0419.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0022

Cite this RCB Cat# RCB0419, RRID:CVCL_0022
Organism: Homo sapiens
Disease: Glioblastoma
Category: Cancer cell line
Comment: Problematic cell line: Contaminated/misidentified. This cell line is not the original glioblastoma cell line established in 1968 at the University of Uppsala. As described in PubMed=27582061 it is most probably also a glioblastoma cell line but whose origin is unknow. See U-87MG Uppsala (CVCL_GP63) for the original U-87MG cell line. Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 3. Doubling time: 72 hours (PubMed=25984343). Microsatellite instability: Stable (MSS) (Sanger). Sequence variation: Has no IDH1 mutation (PubMed=19435942). Omics: Cell surface proteome. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Genome sequenced. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Discontinued: RCB; RCB0419.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0022

Cite this ICLC Cat# HTL00013, RRID:CVCL_0022
Organism: Homo sapiens
Disease: Glioblastoma
Category: Cancer cell line
Comment: Problematic cell line: Contaminated/misidentified. This cell line is not the original glioblastoma cell line established in 1968 at the University of Uppsala. As described in PubMed=27582061 it is most probably also a glioblastoma cell line but whose origin is unknow. See U-87MG Uppsala (CVCL_GP63) for the original U-87MG cell line. Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 3. Doubling time: 72 hours (PubMed=25984343). Microsatellite instability: Stable (MSS) (Sanger). Sequence variation: Has no IDH1 mutation (PubMed=19435942). Omics: Cell surface proteome. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Genome sequenced. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Discontinued: RCB; RCB0419.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0022

Cite this CLS Cat# 300367/p658_U-87_MG, RRID:CVCL_0022
Organism: Homo sapiens
Disease: Glioblastoma
Category: Cancer cell line
Comment: Problematic cell line: Contaminated/misidentified. This cell line is not the original glioblastoma cell line established in 1968 at the University of Uppsala. As described in PubMed=27582061 it is most probably also a glioblastoma cell line but whose origin is unknow. See U-87MG Uppsala (CVCL_GP63) for the original U-87MG cell line. Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 3. Doubling time: 72 hours (PubMed=25984343). Microsatellite instability: Stable (MSS) (Sanger). Sequence variation: Has no IDH1 mutation (PubMed=19435942). Omics: Cell surface proteome. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Genome sequenced. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Discontinued: RCB; RCB0419.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0022

Cite this BCRJ Cat# 0241, RRID:CVCL_0022
Organism: Homo sapiens
Disease: Glioblastoma
Category: Cancer cell line
Comment: Problematic cell line: Contaminated/misidentified. This cell line is not the original glioblastoma cell line established in 1968 at the University of Uppsala. As described in PubMed=27582061 it is most probably also a glioblastoma cell line but whose origin is unknow. See U-87MG Uppsala (CVCL_GP63) for the original U-87MG cell line. Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 3. Doubling time: 72 hours (PubMed=25984343). Microsatellite instability: Stable (MSS) (Sanger). Sequence variation: Has no IDH1 mutation (PubMed=19435942). Omics: Cell surface proteome. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Genome sequenced. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Discontinued: RCB; RCB0419.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0022

Cite this IZSLER Cat# BS TCL 189, RRID:CVCL_0022
Organism: Homo sapiens
Disease: Glioblastoma
Category: Cancer cell line
Comment: Problematic cell line: Contaminated/misidentified. This cell line is not the original glioblastoma cell line established in 1968 at the University of Uppsala. As described in PubMed=27582061 it is most probably also a glioblastoma cell line but whose origin is unknow. See U-87MG Uppsala (CVCL_GP63) for the original U-87MG cell line. Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 3. Doubling time: 72 hours (PubMed=25984343). Microsatellite instability: Stable (MSS) (Sanger). Sequence variation: Has no IDH1 mutation (PubMed=19435942). Omics: Cell surface proteome. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Genome sequenced. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Discontinued: RCB; RCB0419.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0022

Cite this ECACC Cat# 89081402, RRID:CVCL_0022
Organism: Homo sapiens
Disease: Glioblastoma
Category: Cancer cell line
Comment: Problematic cell line: Contaminated/misidentified. This cell line is not the original glioblastoma cell line established in 1968 at the University of Uppsala. As described in PubMed=27582061 it is most probably also a glioblastoma cell line but whose origin is unknow. See U-87MG Uppsala (CVCL_GP63) for the original U-87MG cell line. Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 3. Doubling time: 72 hours (PubMed=25984343). Microsatellite instability: Stable (MSS) (Sanger). Sequence variation: Has no IDH1 mutation (PubMed=19435942). Omics: Cell surface proteome. Omics: CNV analysis. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Genome sequenced. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Discontinued: RCB; RCB0419.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0023

Cite this KCLB Cat# 10185, RRID:CVCL_0023
Organism: Homo sapiens
Disease: Lung adenocarcinoma
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 2. Part of: JFCR39 cancer cell line panel. Part of: KuDOS 95 cell line panel. Part of: MD Anderson Cell Lines Project. Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982). Part of: NCI60 cancer cell line panel. Doubling time: 18 hours (in RPMI 1640+10% FBS), 37 hours (in ACL-3), 36 hours (in ACL-3+BSA) (PubMed=3940644); 22 hours (PubMed=25984343); 27 hours (from cell counting), 27 hours (from absorbance) (DOI=10.5897/IJBMBR2013.0154); 22.9 hours (NCI-DTP); ~40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger). Sequence variation: Homozygous for KRAS p.Gly12Ser (PubMed=17088437). Sequence variation: Homozygous for STK11 p.Gln37Ter (PubMed=17088437). Omics: Acetylation analysis by proteomics. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep phosphoproteome analysis. Omics: Deep membrane proteome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: H3K9ac ChIP-seq epigenome analysis. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: Proteome analysis by 2D-DE/MS. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Omics: Virome analysis using proteomics. Misspelling: 'A594' in PubMed=18227028. Misspelling: 'A59' in PubMed=16354588. Discontinued: ATCC; CRL-7909.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0023

Cite this KCB Cat# KCB 200434YJ, RRID:CVCL_0023
Organism: Homo sapiens
Disease: Lung adenocarcinoma
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 2. Part of: JFCR39 cancer cell line panel. Part of: KuDOS 95 cell line panel. Part of: MD Anderson Cell Lines Project. Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982). Part of: NCI60 cancer cell line panel. Doubling time: 18 hours (in RPMI 1640+10% FBS), 37 hours (in ACL-3), 36 hours (in ACL-3+BSA) (PubMed=3940644); 22 hours (PubMed=25984343); 27 hours (from cell counting), 27 hours (from absorbance) (DOI=10.5897/IJBMBR2013.0154); 22.9 hours (NCI-DTP); ~40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger). Sequence variation: Homozygous for KRAS p.Gly12Ser (PubMed=17088437). Sequence variation: Homozygous for STK11 p.Gln37Ter (PubMed=17088437). Omics: Acetylation analysis by proteomics. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep phosphoproteome analysis. Omics: Deep membrane proteome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: H3K9ac ChIP-seq epigenome analysis. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: Proteome analysis by 2D-DE/MS. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Omics: Virome analysis using proteomics. Misspelling: 'A594' in PubMed=18227028. Misspelling: 'A59' in PubMed=16354588. Discontinued: ATCC; CRL-7909.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0023

Cite this TKG Cat# TKG 0184, RRID:CVCL_0023
Organism: Homo sapiens
Disease: Lung adenocarcinoma
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 2. Part of: JFCR39 cancer cell line panel. Part of: KuDOS 95 cell line panel. Part of: MD Anderson Cell Lines Project. Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982). Part of: NCI60 cancer cell line panel. Doubling time: 18 hours (in RPMI 1640+10% FBS), 37 hours (in ACL-3), 36 hours (in ACL-3+BSA) (PubMed=3940644); 22 hours (PubMed=25984343); 27 hours (from cell counting), 27 hours (from absorbance) (DOI=10.5897/IJBMBR2013.0154); 22.9 hours (NCI-DTP); ~40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger). Sequence variation: Homozygous for KRAS p.Gly12Ser (PubMed=17088437). Sequence variation: Homozygous for STK11 p.Gln37Ter (PubMed=17088437). Omics: Acetylation analysis by proteomics. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep phosphoproteome analysis. Omics: Deep membrane proteome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: H3K9ac ChIP-seq epigenome analysis. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: Proteome analysis by 2D-DE/MS. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Omics: Virome analysis using proteomics. Misspelling: 'A594' in PubMed=18227028. Misspelling: 'A59' in PubMed=16354588. Discontinued: ATCC; CRL-7909.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0023

Cite this RCB Cat# RCB0098, RRID:CVCL_0023
Organism: Homo sapiens
Disease: Lung adenocarcinoma
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 2. Part of: JFCR39 cancer cell line panel. Part of: KuDOS 95 cell line panel. Part of: MD Anderson Cell Lines Project. Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982). Part of: NCI60 cancer cell line panel. Doubling time: 18 hours (in RPMI 1640+10% FBS), 37 hours (in ACL-3), 36 hours (in ACL-3+BSA) (PubMed=3940644); 22 hours (PubMed=25984343); 27 hours (from cell counting), 27 hours (from absorbance) (DOI=10.5897/IJBMBR2013.0154); 22.9 hours (NCI-DTP); ~40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger). Sequence variation: Homozygous for KRAS p.Gly12Ser (PubMed=17088437). Sequence variation: Homozygous for STK11 p.Gln37Ter (PubMed=17088437). Omics: Acetylation analysis by proteomics. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep phosphoproteome analysis. Omics: Deep membrane proteome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: H3K9ac ChIP-seq epigenome analysis. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: Proteome analysis by 2D-DE/MS. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Omics: Virome analysis using proteomics. Misspelling: 'A594' in PubMed=18227028. Misspelling: 'A59' in PubMed=16354588. Discontinued: ATCC; CRL-7909.

  • From Current Category

http://web.expasy.org/cellosaurus/CVCL_0023

Cite this ATCC Cat# CCL-185, RRID:CVCL_0023
Organism: Homo sapiens
Disease: Lung adenocarcinoma
Category: Cancer cell line
Comment: Part of: Cancer Cell Line Encyclopedia (CCLE) project. Part of: ENCODE project common cell types; tier 2. Part of: JFCR39 cancer cell line panel. Part of: KuDOS 95 cell line panel. Part of: MD Anderson Cell Lines Project. Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982). Part of: NCI60 cancer cell line panel. Doubling time: 18 hours (in RPMI 1640+10% FBS), 37 hours (in ACL-3), 36 hours (in ACL-3+BSA) (PubMed=3940644); 22 hours (PubMed=25984343); 27 hours (from cell counting), 27 hours (from absorbance) (DOI=10.5897/IJBMBR2013.0154); 22.9 hours (NCI-DTP); ~40 hours (DSMZ). Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger). Sequence variation: Homozygous for KRAS p.Gly12Ser (PubMed=17088437). Sequence variation: Homozygous for STK11 p.Gln37Ter (PubMed=17088437). Omics: Acetylation analysis by proteomics. Omics: Deep antibody staining analysis. Omics: Deep exome analysis. Omics: Deep phosphoproteome analysis. Omics: Deep membrane proteome analysis. Omics: Deep proteome analysis. Omics: Deep RNAseq analysis. Omics: DNA methylation analysis. Omics: Fluorescence phenotype profiling. Omics: H3K4me3 ChIP-seq epigenome analysis. Omics: H3K9ac ChIP-seq epigenome analysis. Omics: lncRNA expression profiling. Omics: Metabolome analysis. Omics: Protein expression by reverse-phase protein arrays. Omics: Proteome analysis by 2D-DE/MS. Omics: shRNA library screening. Omics: SNP array analysis. Omics: Transcriptome analysis. Omics: Virome analysis using proteomics. Misspelling: 'A594' in PubMed=18227028. Misspelling: 'A59' in PubMed=16354588. Discontinued: ATCC; CRL-7909.

  • From Current Category

  1. Resource Identification Portal Resources

    Welcome to the RRID Resources search. From here you can search through a compilation of resources used by RRID and see how data is organized within our community.

  2. Navigation

    You are currently on the Community Resources tab looking through categories and sources that RRID has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.

  3. Logging in and Registering

    If you have an account on RRID then you can log in from here to get additional features in RRID such as Collections, Saved Searches, and managing Resources.

  4. Searching

    Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:

    1. Use quotes around phrases you want to match exactly
    2. You can manually AND and OR terms to change how we search between words
    3. You can add "-" to terms to make sure no results return with that term in them (ex. Cerebellum -CA1)
    4. You can add "+" to terms to require they be in the data
    5. Using autocomplete specifies which branch of our semantics you with to search and can help refine your search
  5. Save Your Search

    You can save any searches you perform for quick access to later from here.

  6. Query Expansion

    We recognized your search term and included synonyms and inferred terms along side your term to help get the data you are looking for.

  7. Collections

    If you are logged into RRID you can add data records to your collections to create custom spreadsheets across multiple sources of data.

  8. Sources

    Here are the sources that were queried against in your search that you can investigate further.

  9. Categories

    Here are the categories present within RRID that you can filter your data on

  10. Subcategories

    Here are the subcategories present within this category that you can filter your data on

  11. Further Questions

    If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.

X